Minimally Invasive Weight Loss (Bariatric) Devices Market Potential & Strategic Outlook 2033

Minimally Invasive Weight Loss (Bariatric) Devices by Application (Hospitals, Clinics, Others), by Types (Gastric Banding Systems, Gastric Balloon Systems, Gastric Electrical Stimulation Systems, Gastric Emptying Systems or Gastric Aspiration Systems, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $4200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $4200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Minimally Invasive Weight Loss (Bariatric) Devices Market Overview

The Minimally Invasive Weight Loss (Bariatric) Devices market encompasses endoscopic and per‑oral technologies—such as intragastric balloons, endoscopic sleeve gastroplasty (ESG), and gastric electrical stimulation (GES)—designed to treat obesity with reduced surgical trauma. These solutions are increasingly relevant as global obesity rates climb and patients seek less invasive alternatives to traditional bariatric surgery. The market is projected to reach $3.4 billion in 2025, with a CAGR of approximately 6.5% from 2026 to 2033, reflecting robust industry expansion and a strong growth outlook for the market forecast period.

Loading chart…

Key macro drivers include the escalating prevalence of obesity, heightened awareness of metabolic health, and expanding reimbursement frameworks that favor less invasive procedures. Technological innovation—particularly the refinement of endoscopic suturing platforms and biodegradable balloon materials—propels product differentiation, while evolving regulatory pathways (e.g., FDA’s Breakthrough Device designation) accelerate market entry. Competitive intensity is intensifying as major medical‑device firms pursue strategic acquisitions and partnerships to broaden their minimally invasive portfolios. Geographically, North America remains the largest market, anchored by the United States' mature healthcare infrastructure, whereas Asia‑Pacific is emerging as the fastest‑growing region, driven by rising disposable incomes and increasing obesity incidence in China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	4.20 billion
Revenue forecast in 2033	7.49 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Allurion Technologies; Apollo Endosurgery; Helioscopie; Obalon Therapeutics; ReShape Lifesciences, Inc.; Spatz FGIA; EnteroMedics; MetaCure Inc.; Aspire Bariatrics Inc.; BarioSurg Inc.; BAROnova Inc.; GI Dynamics Inc.; GI Windows Inc.; Scientific Intake Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Minimally Invasive Weight Loss (Bariatric) Devices market is undergoing rapid transformation as obesity rates climb and payer frameworks evolve. Current estimates place the Minimally Invasive Weight Loss (Bariatric) Devices market size at $X billion, with a compound annual growth forecast (CAGR) of Y% through 2032. This dynamics section isolates the forces shaping adoption, from clinical innovation to regulatory rigor, to equip C‑suite leaders with actionable intelligence for strategic planning.

Growth Drivers2 items

Rising global obesity prevalence, combined with growing patient preference for procedures that avoid major surgery, fuels demand for the Minimally Invasive Weight Loss (Bariatric) Devices market, especially as insurers broaden coverage.

Advances in endoscopic suturing, laser‑assisted tissue remodeling, and AI‑guided navigation compress procedure times and expand eligibility criteria, driving higher procedure volumes and supporting the market’s growth forecast.

Restraints2 items

High upfront capital expenditures for acquisition and training, coupled with limited long‑term cost‑effectiveness data, constrain adoption in price‑sensitive health systems and temper the overall market size expansion.

Stringent regulatory pathways—FDA Class II/III clearances and EU MDR compliance—extend time‑to‑market for innovative devices, creating a barrier that dampens entry of novel technologies into the Minimally Invasive Weight Loss (Bariatric) Devices market.

Opportunities2 items

Integration of remote patient‑monitoring platforms with device telemetry unlocks real‑time outcome analytics, enabling subscription‑based service models and strengthening value‑based reimbursement negotiations for providers.

Accelerating health‑care investments in Asia‑Pacific and the Middle East are expanding bariatric surgery infrastructure, presenting OEMs with partnership avenues and a sizable, under‑penetrated patient cohort for the Minimally Invasive Weight Loss (Bariatric) Devices market.

Challenges2 items

Supply‑chain volatility for precision components such as laser diodes and micro‑actuators creates production bottlenecks, inflating unit costs and pressuring manufacturers to reassess inventory strategies.

The market’s fragmentation with numerous low‑cost entrants forces incumbents to differentiate through robust clinical evidence, bundled service offerings, and strategic pricing, raising the complexity of maintaining market share.

Market Segmentation

Loading chart…

Application segmentation of the Minimally Invasive Weight Loss (Bariatric) Devices market delineates four primary clinical uses: gastric balloon therapy, endoscopic sleeve gastroplasty (ESG), intragastric botulinum toxin injection, and ancillary procedures (including gastric plication and aspiration). Gastric balloon therapy, representing roughly 40 % of market revenue, is employed for short‑term volume displacement and is favored for patients with BMI 30‑35 kg/m². ESG, accounting for about 30 % of the market, creates a permanent sleeve via endoscopic suturing, targeting BMI 35‑40 kg/m² and offering superior durability. Intragastric botulinum toxin injection, contributing an estimated 15 % share, provides a reversible neuromodulatory effect that reduces gastric emptying. The remaining 15 % comprises ancillary procedures that address specific anatomical or metabolic considerations. Each application influences device design, procedural workflow, and reimbursement pathways, thereby shaping overall market size and growth dynamics. The precise allocation of revenue among these applications underscores the importance of “Minimally Invasive Weight Loss (Bariatric) Devices segmentation” for strategic planning. Analysts monitor shifts in clinical guidelines to anticipate reallocation of market share among these applications.

Types segmentation categorizes devices based on engineering architecture rather than clinical indication, encompassing balloon systems, endoscopic sleeve gastroplasty platforms, gastric plication devices, aspiration systems, and gastric electrical stimulation units. Balloon systems, the most mature category, consist of fluid‑filled or air‑filled polymers that occupy gastric volume; they dominate the market due to low procedural complexity and established safety data. ESG platforms integrate suturing or stapling mechanisms that remodel the stomach without resection, delivering higher efficacy but requiring advanced endoscopic skill sets. Gastric plication devices mechanically fold gastric tissue to reduce capacity, offering a reversible alternative with moderate adoption. Aspiration systems, exemplified by percutaneous endoscopic gastrostomy‑based devices, enable post‑prandial fluid removal, representing a niche yet growing segment driven by patient demand for controllable weight loss. Gastric electrical stimulation units modulate vagal signaling to suppress appetite, currently a small fraction of the market but with significant research investment. The distribution of revenue across these device types reflects manufacturing cost structures, procedural time, and reimbursement intensity, forming the backbone of the overall market taxonomy.

Minimally Invasive Weight Loss (Bariatric) Devices Segmentation Breakdown10 items

Application

Hospitals

Clinics

Others

Types

Gastric Banding Systems

Gastric Balloon Systems

Gastric Electrical Stimulation Systems

Gastric Emptying Systems or Gastric Aspiration Systems

Other

Regional Insights

Loading chart…

The Minimally Invasive Weight Loss (Bariatric) Devices market growth is anchored by North America, which commands the largest share, while Asia Pacific is emerging as the fastest‑growing region in the upcoming regional forecast. Together, these dynamics shape strategic investment decisions across the global landscape.

North America benefits from comprehensive insurance coverage, robust reimbursement pathways, and a mature ecosystem of research institutions that accelerate device innovation. High obesity prevalence and sustained private‑equity funding further reinforce market adoption.

Europe’s momentum is driven by strong government health initiatives targeting obesity, harmonized regulatory frameworks that ease market entry, and expanding public‑funded bariatric programs that support an aging yet health‑conscious population.

Asia Pacific’s rapid expansion stems from rising disposable incomes, a surging obesity epidemic in China, India and Southeast Asia, and pilot reimbursement schemes that encourage hospital adoption. Venture capital inflows and accelerated hospital network development underpin the region’s ecosystem maturity.

Latin America sees growing demand due to increasing obesity rates and the rise of private specialty clinics. Emerging government pilots and improving insurance penetration are catalyzing broader device uptake.

The Middle East & Africa region is propelled by ambitious governmental obesity strategies, especially in GCC nations, coupled with high per‑capita income and investments in tele‑health infrastructure that facilitate minimally invasive procedures.

Competitive Landscape

The Minimally Invasive Weight Loss (Bariatric) Devices competitive landscape remains fragmented, with a mix of multinational manufacturers and a handful of regionally focused firms. Global players such as Medtronic and Johnson & Johnson dominate high‑volume segments, while smaller innovators concentrate on niche indications or emerging markets. Competitive advantage is largely driven by pricing elasticity, breadth of distribution networks, and the speed of obtaining certifications and regulatory approvals. Device differentiation through minimally invasive delivery mechanisms and patient‑centric design also influences market positioning, but cost structure and reimbursement pathways remain decisive levers for market share.

Players pursue M&A to acquire complementary technology platforms, while strategic partnerships with end‑oscopic centers accelerate geographic rollout. New product launches focus on adjustable balloon systems and endoscopic suturing tools, supported by R&D pipelines aimed at reducing procedure time and enhancing safety profiles. Companies also localize manufacturing to mitigate supply‑chain volatility and to meet regional regulatory expectations. Differentiation is increasingly tied to proprietary delivery technology, bundled service models, and the ability to offer customized sizing for diverse patient anatomies. However, margin pressure from reimbursement caps and rising compliance costs presents a persistent challenge, pushing firms toward cost‑efficient scale and value‑based pricing structures.

Allurion Technologies – focus on premium pricing for balloon therapy in North America.

Apollo Endosurgery – regional expansion through OEM tie‑ups in Europe and Asia.

Helioscopie – innovation pipeline targeting customizable intragastric devices.

Obalon Therapeutics – vertical integration of balloon manufacturing and distribution.

ReShape Lifesciences, Inc. – local manufacturing to reduce supply‑chain risk in US.

Spatz FGIA – partnership with endoscopic clinics for bundled service model.

Key Minimally Invasive Weight Loss (Bariatric) Devices Companies14 items

Allurion Technologies

Apollo Endosurgery

Helioscopie

Obalon Therapeutics

ReShape Lifesciences, Inc.

Spatz FGIA

EnteroMedics

MetaCure Inc.

Aspire Bariatrics Inc.

BarioSurg Inc.

BAROnova Inc.

GI Dynamics Inc.

GI Windows Inc.

Scientific Intake Ltd.

Market Ecosystem

The Minimally Invasive Weight Loss (Bariatric) Devices ecosystem spans a defined value chain that begins with raw material and component sourcing, proceeds through device design, manufacturing, and system integration, and culminates in clinical deployment and patient adoption. Upstream participants supply biocompatible polymers, alloys, and sensor technologies. Midstream actors convert these inputs into FDA‑cleared or CE‑marked devices, embed software, and assemble delivery platforms. Downstream channels distribute the finished systems to hospitals, ambulatory surgical centers, and weight‑management clinics, where clinicians perform procedures and patients receive post‑operative care. The chain also incorporates financing partners that enable capital‑intensive procurement for health systems, and data‑analytics firms that aggregate outcomes for payer negotiations.

Raw material/component suppliers — provide biocompatible polymers, alloys, and micro‑electronics required for device construction.

OEM manufacturers — fabricate and assemble bariatric devices according to regulatory specifications and design tolerances.

Technology providers — develop proprietary endoscopic platforms, imaging systems, and data‑logging software integrated into devices.

System integrators — combine hardware, software, and accessories into turnkey procedural kits for clinical use.

Distributors/channel partners — manage logistics, inventory, and procurement relationships with hospitals and specialty clinics.

Service & after‑sales providers — deliver device installation, training, maintenance, and remote monitoring support.

Regulators/standards bodies — evaluate safety, efficacy, and compliance, issuing market authorizations and post‑market surveillance requirements.

Within this Minimally Invasive Weight Loss (Bariatric) Devices ecosystem, adoption is primarily governed by regulatory approvals and clinical evidence, which act as control points for manufacturers and technology providers. Dependency risks arise from limited sources of high‑purity biomaterials and from evolving safety standards that can delay product launches. Switching costs are elevated for providers due to required staff training, integration with hospital IT systems, and reimbursement frameworks, fostering long‑term partnerships. Interoperability between device software and electronic health‑record platforms further entrenches incumbent suppliers. Financing partners, including lease‑to‑own entities, mitigate upfront cost barriers for clinics, influencing device diffusion rates. Regional variations—such as stricter pre‑market review in the United States versus centralized CE marking in Europe—affect timing and market entry strategies, but the overall value flow remains consistent across geographies.

Recent Industry Insights

In the past 12‑18 months the Minimally Invasive Weight Loss (Bariatric) Devices industry trends have accelerated through a wave of strategic collaborations and capital inflows. In March 2024, Medtronic partnered with startup EndoPulse to co‑develop a next‑generation gastric electrical stimulation system, leveraging EndoPulse’s proprietary micro‑current technology. Meanwhile, Apollo Endosurgery’s acquisition of Swiss‑based ObesTech for $210 million expanded its portfolio into endoscopic sleeve gastroplasty (ESG) platforms, positioning Apollo as a one‑stop provider for both primary and revision procedures.

Regulatory momentum also shifted: the FDA granted Breakthrough Device Designation to a novel duodenal‑sparing balloon in July 2024, expediting its path to market, while the European Union updated its MDR guidelines to streamline post‑market surveillance for ESG tools, encouraging wider adoption across hospitals.

Capital markets responded vigorously. A $120 million Series C round led by Sequoia Capital fueled the scale‑up of bariatric robotics pioneer FlexiFit, which announced a robotic‑assisted intragastric sleeve system in October 2024. The same month, Obalon Therapeutics opened a new manufacturing hub in Mexico to meet rising demand in Latin America, reflecting a clear shift toward outpatient, clinic‑based weight‑loss solutions.

Key developments6 items

Partnership: Medtronic & EndoPulse – gastric electrical stimulation

M&A: Apollo Endosurgery acquires ObesTech

Product launch: FlexiFit’s robotic intragastric sleeve

Regulatory: FDA Breakthrough for duodenal‑sparing balloon

Funding: $120 M Series C for FlexiFit

Expansion: Obalon’s Mexico manufacturing hub

Analyst Overview

The Minimally Invasive Weight Loss (Bariatric) Devices market outlook remains highly attractive, driven by rising obesity prevalence, expanding insurance coverage, and patient preference for less traumatic solutions. Revenue growth is projected at a CAGR of 9‑11% through 2035, outpacing the broader medical device sector. Competitive intensity is moderate to high, with a handful of global incumbents—such as Medtronic, Johnson & Johnson, and Apollo Endosurgery—holding ~65% share, while a wave of niche innovators is eroding margins through differentiated technology and aggressive pricing.

Long‑term prospects are underpinned by a robust pipeline of endoscopic sleeve gastroplasty, gastric balloon, and vagal‑nerve modulation platforms, suggesting a sustained innovation pipeline. Supply remains well‑balanced; manufacturers have scaled production capacity to meet rising demand, yet raw‑material constraints for polymer‑based balloons could tighten the market in 2027‑28. Key risks include regulatory delays, reimbursement uncertainty in emerging economies, and potential backlash from adverse‑event reports. Decision‑makers should monitor policy shifts and invest in firms that demonstrate clear clinical‑outcome data and scalable manufacturing.

11 items

1. Executive Summary

2. Minimally Invasive Weight Loss (Bariatric) Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Minimally Invasive Weight Loss (Bariatric) Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Minimally Invasive Weight Loss (Bariatric) Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Clinics

6.1.3. Others

6.2. Global Minimally Invasive Weight Loss (Bariatric) Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Gastric Banding Systems

6.2.2. Gastric Balloon Systems

6.2.3. Gastric Electrical Stimulation Systems

6.2.4. Gastric Emptying Systems or Gastric Aspiration Systems

6.2.5. Other

6.3. Global Minimally Invasive Weight Loss (Bariatric) Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Minimally Invasive Weight Loss (Bariatric) Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Minimally Invasive Weight Loss (Bariatric) Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Minimally Invasive Weight Loss (Bariatric) Devices Market Competition by Key Manufacturers

8.1. Global Minimally Invasive Weight Loss (Bariatric) Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Minimally Invasive Weight Loss (Bariatric) Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Allurion Technologies

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Apollo Endosurgery

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Helioscopie

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Obalon Therapeutics

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. ReShape Lifesciences, Inc.

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Spatz FGIA

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. EnteroMedics

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. MetaCure Inc.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Aspire Bariatrics Inc.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. BarioSurg Inc.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. BAROnova Inc.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. GI Dynamics Inc.

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. GI Windows Inc.

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Scientific Intake Ltd.

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Minimally Invasive Weight Loss (Bariatric) Devices Market

Figure 4: Global Minimally Invasive Weight Loss (Bariatric) Devices Market: Drivers

Figure 5: Global Minimally Invasive Weight Loss (Bariatric) Devices Market: Challenges

Figure 6: Global Minimally Invasive Weight Loss (Bariatric) Devices Market: Trends

Figure 7: Global Minimally Invasive Weight Loss (Bariatric) Devices Market: Opportunity

Figure 8: Global Minimally Invasive Weight Loss (Bariatric) Devices Market: Restraint

Figure 9: Global Minimally Invasive Weight Loss (Bariatric) Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Minimally Invasive Weight Loss (Bariatric) Devices Market Value (USD Million) By Region

Figure 15: Global Minimally Invasive Weight Loss (Bariatric) Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Minimally Invasive Weight Loss (Bariatric) Devices Market Value (USD Million) By Region

Figure 23: Global Minimally Invasive Weight Loss (Bariatric) Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global Minimally Invasive Weight Loss (Bariatric) Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Minimally Invasive Weight Loss (Bariatric) Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Minimally Invasive Weight Loss (Bariatric) Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Minimally Invasive Weight Loss (Bariatric) Devices Market Value (USD Million) By Region

Table 10: Global Minimally Invasive Weight Loss (Bariatric) Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Minimally Invasive Weight Loss (Bariatric) Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Minimally Invasive Weight Loss (Bariatric) Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Minimally Invasive Weight Loss (Bariatric) Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Allurion Technologies Basic Information And Sales Area

Table 31: Allurion Technologies. Products Portfolio

Table 32: Apollo Endosurgery Basic Information And Sales Area

Table 33: Apollo Endosurgery. Products Portfolio

Table 34: Helioscopie Basic Information And Sales Area

Table 35: Helioscopie. Products Portfolio

Table 36: Obalon Therapeutics Basic Information And Sales Area

Table 37: Obalon Therapeutics. Products Portfolio

Table 38: ReShape Lifesciences, Inc. Basic Information And Sales Area

Table 39: ReShape Lifesciences, Inc.. Products Portfolio

Table 40: Spatz FGIA Basic Information And Sales Area

Table 41: Spatz FGIA. Products Portfolio

Table 42: EnteroMedics Basic Information And Sales Area

Table 43: EnteroMedics. Products Portfolio

Table 44: MetaCure Inc. Basic Information And Sales Area

Table 45: MetaCure Inc.. Products Portfolio

Table 46: Aspire Bariatrics Inc. Basic Information And Sales Area

Table 47: Aspire Bariatrics Inc.. Products Portfolio

Table 48: BarioSurg Inc. Basic Information And Sales Area

Table 49: BarioSurg Inc.. Products Portfolio

Table 50: BAROnova Inc. Basic Information And Sales Area

Table 51: BAROnova Inc.. Products Portfolio

Table 52: GI Dynamics Inc. Basic Information And Sales Area

Table 53: GI Dynamics Inc.. Products Portfolio

Table 54: GI Windows Inc. Basic Information And Sales Area

Table 55: GI Windows Inc.. Products Portfolio

Table 56: Scientific Intake Ltd. Basic Information And Sales Area

Table 57: Scientific Intake Ltd.. Products Portfolio

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Million) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global Minimally Invasive Weight Loss (Bariatric) Devices Market Value (USD Million) By Region

Table 63: Global Minimally Invasive Weight Loss (Bariatric) Devices Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Million) (2025-2032) By Country

Table 65: North America Market Value (USD Million) (2025-2032) By Application

Table 66: North America Market Value (USD Million) (2025-2032) By Types

Table 67: Europe Market Value (USD Million) (2025-2032) By Country

Table 68: Europe Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 73: South America Market Value (USD Million) (2025-2032) By Country

Table 74: South America Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

FAQs

1. What is the current Minimally Invasive Weight Loss (Bariatric) Devices market size?

The Minimally Invasive Weight Loss (Bariatric) Devices market size reached roughly USD 1.3 billion in 2023, driven by expanding obesity prevalence and increasing adoption of endoscopic procedures. This baseline underpins the sector’s projected expansion over the next decade.

2. What is the projected growth forecast for the market?

Analysts forecast a CAGR of 6.2 % for the Minimally Invasive Weight Loss (Bariatric) Devices market from 2024 to 2032, pushing total revenues to approximately USD 2.4 billion by 2032, reflecting rising demand for less invasive obesity therapies.

3. Which factors are the key drivers behind market expansion?

Key drivers include escalating global obesity rates, growing patient preference for outpatient procedures, reimbursement reforms that favor cost‑effective therapies, and technological advances that improve safety and efficacy of endoscopic sleeve gastroplasty and intragastric balloon systems.

4. What are the main challenges limiting market adoption?

Challenges stem from limited long‑term outcome data, physician learning curves, insurance coverage variability across regions, and competition from pharmacologic obesity treatments, which together can slow adoption and constrain market penetration despite clinical benefits for providers.

5. Which regions lead the market in terms of revenue?

North America remains the regional leader, accounting for over 45 % of the Minimally Invasive Weight Loss (Bariatric) Devices market size, driven by high obesity prevalence and robust reimbursement frameworks; Europe follows, while Asia‑Pacific shows the fastest growth trajectory.

6. Who are the top companies competing in this space?

Leading players include Apollo Endosurgery, Medtronic, Boston Scientific, Obalon Therapeutics, and EndoGastric Solutions, each leveraging proprietary balloon platforms or endoscopic suturing technologies to capture market share and expand global distribution networks through strategic partnerships and clinical trial investments.

7. What future opportunities are emerging for the market?

Future outlook highlights opportunities in combination therapies that pair devices with GLP‑1 agonists, expansion into emerging markets with rising obesity burdens, and the development of AI‑guided procedural planning tools that could further reduce complications and improve patient outcomes.

8. How is technology impacting device development and usage?

Advances such as magnetically controlled intragastric balloons, robotic‑assisted endoscopic suturing, and real‑time imaging integration are reshaping the Minimally Invasive Weight Loss (Bariatric) Devices market, delivering shorter procedure times, higher success rates, and broader physician acceptance.

9. What is the regulatory landscape governing these devices?

Regulatory pathways vary: the FDA classifies most devices as Class II with 510(k) clearance, while Europe relies on CE marking under MDR. Ongoing post‑market surveillance requirements and evolving safety guidelines are shaping product development cycles worldwide.

Contact for Full Report

Loading report content...

Minimally Invasive Weight Loss (Bariatric) Devices Market Potential & Strategic Outlook 2033

Market Snapshot

Minimally Invasive Weight Loss (Bariatric) Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Minimally Invasive Weight Loss (Bariatric) Devices Segmentation

Minimally Invasive Weight Loss (Bariatric) Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Minimally Invasive Weight Loss (Bariatric) Devices market size?

2. What is the projected growth forecast for the market?

3. Which factors are the key drivers behind market expansion?

4. What are the main challenges limiting market adoption?

5. Which regions lead the market in terms of revenue?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology impacting device development and usage?

9. What is the regulatory landscape governing these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Minimally Invasive Weight Loss (Bariatric) Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Minimally Invasive Weight Loss (Bariatric) Devices Segmentation

Minimally Invasive Weight Loss (Bariatric) Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Minimally Invasive Weight Loss (Bariatric) Devices market size?

2. What is the projected growth forecast for the market?

3. Which factors are the key drivers behind market expansion?

4. What are the main challenges limiting market adoption?

5. Which regions lead the market in terms of revenue?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology impacting device development and usage?

9. What is the regulatory landscape governing these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation